NCT06788314View on ClinicalTrials.gov

A Study of Enalapril in Treatment of Venous Malformations

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 1, 2029

Study Completion Date

December 1, 2030

Conditions
Venous MalformationPainQuality of LifeVascular Malformation
Interventions
DRUG

Enalapril

"Each participant will receive a dose of enalapril 5 mg once daily. If the participant doesn't have effect of the intervention after 3 months, the dose of enalapril will be increased to 10 mg daily, if the tolerance of enalapril is good. Lack of effect will be defined as unchanged or increased NRS score.~Treatment duration will be 12 months."

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Rikshospitalet, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER